Literature DB >> 26770091

Escharotic Treatment for ECC-positive CIN3 in Childbearing Years: A Case Report.

Kimberly Windstar1, Corina Dunlap1, Heather Zwickey1.   

Abstract

A persistent human papillomavirus (HPV) infection of a high-risk type is necessary for cervical cancer to develop. The severity of the diagnosis, together with colposcopy findings, determines the standard for treatment, and ablative or excisional options may be recommended. Escharotic treatment, together with an oral, anticarcinogenic HPV protocol and a vaginal-suppository protocol, is an alternative treatment, especially for those women of childbearing age who are concerned about the possibility of obstetrical complications associated with the use of loop electrosurgical excision (LEEP). The aim of the current case study was to observe the effect of an ablative escharotic treatment for a woman with severe dysplasia, cervical intraepithelial neoplasia grade 3 (CIN3). A 28-y-old female visited the National College of Natural Medicine clinic to obtain suggestions for alternative treatments following a satisfactory colposcopy and a biopsy revealing a high-risk HPV effect, severe dysplasia CIN3, and a positive endocervical curettage (ECC). She refused the recommended standard of care, a LEEP, because of concerns about the potential for future obstetrical complications. As an alternative, she elected to receive an escharotic treatment at a frequency of 2 treatments/wk for 5 wk. In addition to the escharotic treatment, she followed an oral protocol consisting of vitamins and botanical medicine for 1 y and she completed a 12-wk regime of vaginal suppositories following the escharotic. The authors followed her for 2 y. The woman's Papanicolaou (Pap) test at the 6-mo follow-up revealed negative cervical cytology for intraepithelial lesion or malignancy, and her follow-up ECC was negative. Liquid-based Pap results were normal, and HPV testing was negative at her 1-y follow-up. Her Pap continued to remain normal at her 2-y follow-up. For women with high-grade cervical neoplasias and positive ECCs, with satisfactory colposcopies, escharotic treatment, accompanied by oral supplementation, holds promise as an effective alternative to LEEP and other excisional procedures.

Entities:  

Year:  2014        PMID: 26770091      PMCID: PMC4684126     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  36 in total

1.  Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.

Authors:  Qunzhou Zhang; Xudong Tang; Qingyi Lu; Zuofeng Zhang; Jianyu Rao; Anh D Le
Journal:  Mol Cancer Ther       Date:  2006-05       Impact factor: 6.261

2.  Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells.

Authors:  N Ahmad; S Gupta; M M Husain; K M Heiskanen; H Mukhtar
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

3.  Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium.

Authors:  D Z Chen; M Qi; K J Auborn; T H Carter
Journal:  J Nutr       Date:  2001-12       Impact factor: 4.798

4.  Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap.

Authors:  V Graham; E S Surwit; S Weiner; F L Meyskens
Journal:  West J Med       Date:  1986-08

5.  The role of triterpenoids in the topical anti-inflammatory activity of Calendula officinalis flowers.

Authors:  R Della Loggia; A Tubaro; S Sosa; H Becker; S Saar; O Isaac
Journal:  Planta Med       Date:  1994-12       Impact factor: 3.352

6.  Loop electrosurgical excision procedure and the risk for preterm birth.

Authors:  Maija Jakobsson; Mika Gissler; Jorma Paavonen; Anna-Maija Tapper
Journal:  Obstet Gynecol       Date:  2009-09       Impact factor: 7.661

Review 7.  2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

8.  Mitogenic activity of high molecular polysaccharide fractions isolated from the Cupressaceae Thuja occidentale L. I. Macrophage-dependent induction of CD-4-positive T-helper (Th+) lymphocytes.

Authors:  S H Gohla; H D Haubeck; R D Neth
Journal:  Leukemia       Date:  1988-08       Impact factor: 11.528

9.  Alpha-tocopherol and alpha-tocopheryl quinone levels in cervical intraepithelial neoplasia and cervical cancer.

Authors:  Prabhudas R Palan; Angela L Woodall; Patrick S Anderson; Magdy S Mikhail
Journal:  Am J Obstet Gynecol       Date:  2004-05       Impact factor: 8.661

10.  Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells.

Authors:  Sutapa Mahata; Alok C Bharti; Shirish Shukla; Abhishek Tyagi; Syed A Husain; Bhudev C Das
Journal:  Mol Cancer       Date:  2011-04-15       Impact factor: 27.401

View more
  1 in total

1.  Apoptotic Activities of Sanguinaria canadensis: Primary Human Keratinocytes, C-33A, and Human Papillomavirus HeLa Cervical Cancer Lines.

Authors:  Cynthia Ann Leaver; Hang Yuan; Gwenyth R Wallen
Journal:  Integr Med (Encinitas)       Date:  2018-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.